McIlrath & Eck, LLC
- SEC CIK
- 0001701714
- Latest filing
- May 19, 2026
MRNA holding history
Moderna, Inc. in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRNA overviewAll 13F holders of MRNAFull Q1 2026 holdings
- Shares (Q1 2026)
- 25
- Value
- $1.27K
- % of portfolio
- <0.1%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 25 | $1.27K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 25 | $737 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 25 | $646 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 25 | $690 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 25 | $709 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 25 | $1.04K | <0.1% | −125−83.3% | Reduced | Holders |
| Q3 2024 | 150 | $10.0K | <0.1% | +50+50.0% | Added | Holders |
| Q2 2024 | 100 | $11.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 100 | $10.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 100 | $9.95K | <0.1% | −100−50.0% | Reduced | Holders |
| Q3 2023 | 200 | $20.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 200 | $24.3K | <0.1% | +100+100.0% | Added | Holders |
| Q1 2023 | 100 | $15.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 100 | $18.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 100 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 100 | $14.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 100 | $17.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 100 | $25.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 100 | $38.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 100 | $23.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 100 | $13.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.